Abstract
Recent progress of immunologic aspects of liposomes for medical applications are reviewed. Liposomal application for immunoassay, targeting and adjuvant activity for vaccination are discussed. Development of complement dependent liposome immune lysis assay enabled to measure small amount of serum proteins, such as cancer markers, and extended to various microbial toxins. New technology of targeting for malignant tumors have been developed. The use of liposomes as an safe, versatile, universal adjuvant that can induce humoral and cellmediated immunity to antigen have been investigateted increasingly.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call